BioCardia(BCDA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

BCDA BioCardia

Market Closed 08-21 16:00:00 EDT

1.01

+0.04

+4.44%

盘后1.00

-0.01-0.99%

19:31 EDT

High1.02	Low0.9560	Vol82.46K
Open0.9730	D1 Closing0.9671	Amplitude6.62%
Mkt Cap15.03M	Tradable Cap12.40M	Total Shares14.88M
T/O81.48K	T/O Rate0.67%	Tradable Shares12.27M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"BCDA","market":"US","secType":"STK","nameCN":"BioCardia","latestPrice":1.01,"timestamp":1787342400000,"preClose":0.9671,"halted":0,"volume":82464,"hourTrading":{"tag":"盘后","latestPrice":1,"preClose":1.01,"latestTime":"19:31 EDT","volume":1104,"amount":1103.877,"timestamp":1787355105967,"change":-0.01,"changeRate":-0.009901,"amplitude":0.009901},"delay":0,"changeRate":0.04435942508530664,"floatShares":12272700,"shares":14884328,"eps":-0.73929,"marketStatus":"Market Closed","change":0.0429,"latestTime":"08-21 16:00:00 EDT","open":0.972951,"high":1.02,"low":0.956,"amount":81477.22175712,"amplitude":0.066177,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.73929,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1787558400000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":0.9671,"preHourTrading":{"tag":"盘前","latestPrice":1,"preClose":0.9671,"latestTime":"08:57 EDT","volume":115,"amount":114.446505,"timestamp":1787317051657,"change":0.0329,"changeRate":0.034019,"amplitude":0.051598},"postHourTrading":{"tag":"盘后","latestPrice":1,"preClose":1.01,"latestTime":"19:31 EDT","volume":1104,"amount":1103.877,"timestamp":1787355105967,"change":-0.01,"changeRate":-0.009901,"amplitude":0.009901},"volumeRatio":0.36708421224921595,"impliedVol":0.046,"impliedVolPercentile":0},"requestUrl":"/m/hq/s/BCDA/tweets","defaultTab":"tweets","newsList":[{"id":"2661290656","title":"BioCardia Receives Nasdaq Notice on Minimum Bid Price","url":"https://stock-news.laohu8.com/highlight/detail?id=2661290656","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661290656?lang=en_us&edition=fundamental","pubTime":"2026-08-22 04:59","pubTimestamp":1787345950,"startTime":"0","endTime":"0","summary":"BioCardia ( ($BCDA) ) has issued an update. On August 19, 2026, BioCardia disclosed that it had received a notice from Nasdaq after its common stoc...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/biocardia-receives-nasdaq-notice-on-minimum-bid-price?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/biocardia-receives-nasdaq-notice-on-minimum-bid-price?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NQmain","LCLG","BK4139","BCDA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661297731","title":"BioCardia Receives NASDAQ Notice for Trading Below $1 Minimum Bid Price Requirement","url":"https://stock-news.laohu8.com/highlight/detail?id=2661297731","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661297731?lang=en_us&edition=fundamental","pubTime":"2026-08-22 04:35","pubTimestamp":1787344524,"startTime":"0","endTime":"0","summary":"BioCardia receives Nasdaq notice for trading below $1 minimum bid price requirementBioCardia received a Nasdaq notice on Aug. 19, 2026 for failing the $1 minimum bid price rule for 30 consecutive sess","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260821:nNDLbZlJq2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BCDA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660849696","title":"BioCardia CEO Peter Altman Acquires 5,400 Common Shares Worth $5,022","url":"https://stock-news.laohu8.com/highlight/detail?id=2660849696","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660849696?lang=en_us&edition=fundamental","pubTime":"2026-08-19 00:14","pubTimestamp":1787069690,"startTime":"0","endTime":"0","summary":"BioCardia CEO Peter Altman acquires 5,400 common shares worth $5,022BioCardia President and CEO Peter Altman reported a purchase of 5,400 common shares.The shares were bought at a weighted-average pri","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260818:nNDL6YNrfv:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"BioCardia CEO Peter Altman Acquires 5,400 Common Shares Worth $5,022","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BCDA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659048118","title":"Nasdaq Listing Risks: Potential Delisting Threatens Biocardia’s Market Access and Financial Stability","url":"https://stock-news.laohu8.com/highlight/detail?id=2659048118","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659048118?lang=en_us&edition=fundamental","pubTime":"2026-08-14 14:00","pubTimestamp":1786687248,"startTime":"0","endTime":"0","summary":"Biocardia (BCDA) has disclosed a new risk, in the Share Price & Shareholder Rights category. Biocardia’s reliance on Nasdaq listing exposes investo...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/nasdaq-listing-risks-potential-delisting-threatens-biocardias-market-access-and-financial-stability?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/nasdaq-listing-risks-potential-delisting-threatens-biocardias-market-access-and-financial-stability?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LCLG","NQmain","BK4139","BCDA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659980651","title":"BioCardia CEO Peter Altman Acquires Common Shares Worth $1,748 in Open Market Purchase","url":"https://stock-news.laohu8.com/highlight/detail?id=2659980651","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659980651?lang=en_us&edition=fundamental","pubTime":"2026-08-14 05:43","pubTimestamp":1786657420,"startTime":"0","endTime":"0","summary":"BioCardia CEO Peter Altman acquires common shares worth $1,748 in open market purchaseBioCardia President and CEO Peter Altman bought 1,900 common shares in an open-market purchase at USD 0.92 each.Al","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nNDLF4h1p:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"BioCardia CEO Peter Altman Acquires Common Shares Worth $1,748 in Open Market Purchase","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BCDA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659116221","title":"HeartBeam Q2 Loss Per Share Narrows; Co Lowers FY Net Operating Cash Outflow Guidance","url":"https://stock-news.laohu8.com/highlight/detail?id=2659116221","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659116221?lang=en_us&edition=fundamental","pubTime":"2026-08-14 04:12","pubTimestamp":1786651935,"startTime":"0","endTime":"0","summary":"HeartBeam Q2 loss per share narrows; co lowers FY net operating cash outflow guidanceOverviewU.S. cardiac device maker's Q2 net loss nearly flat yr/yr, loss per share narrowsCompany lowered expected f","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nL1N44A140:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BCDA","BK4082","BEAT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659886181","title":"BioCardia Earnings Call Highlights Regulatory Momentum","url":"https://stock-news.laohu8.com/highlight/detail?id=2659886181","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659886181?lang=en_us&edition=fundamental","pubTime":"2026-08-13 08:10","pubTimestamp":1786579819,"startTime":"0","endTime":"0","summary":"Biocardia (($BCDA)) has held its Q2 earnings call. Read on for the main highlights of the call. BioCardia’s latest earnings call struck a cautiousl...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/biocardia-earnings-call-highlights-regulatory-momentum?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/biocardia-earnings-call-highlights-regulatory-momentum?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BCDA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659188054","title":"BioCardia Inc Reports Results for the Quarter Ended June 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2659188054","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659188054?lang=en_us&edition=fundamental","pubTime":"2026-08-13 05:00","pubTimestamp":1786568450,"startTime":"0","endTime":"0","summary":"BioCardia Inc reports results for the quarter ended June 30 - Earnings SummaryBioCardia IncBCDA.OQreported a quarterly adjusted loss of 13 cents per share for the quarter ended June 30, higher than th","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nL8N449260:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BCDA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659900726","title":"Sera Prognostics Q2 Revenue Rises on Expanded Partnerships and Medicaid Coverage","url":"https://stock-news.laohu8.com/highlight/detail?id=2659900726","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659900726?lang=en_us&edition=fundamental","pubTime":"2026-08-13 04:28","pubTimestamp":1786566507,"startTime":"0","endTime":"0","summary":"Sera Prognostics Q2 revenue rises on expanded partnerships and Medicaid coverageOverviewUS pregnancy diagnostics firm's Q2 revenue rose yr/yr, driven by expanded partnerships and Medicaid coverageComp","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nL1N44912X:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4121","BK4585","LU0205193047.USD","LU0205194284.USD","TECH","IE0034390439.USD","SERA","BK4539","IE00B64QTZ34.USD","LU2237957811.SGD","LU2237957902.USD","QTRX","BK4139","BK4588","BCDA","IE00B19Z6F94.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659900317","title":"BioCardia Q2 FY26 Net Loss Narrows to $1.61 Million; Cash Rises to $4.12 Million as of June 30, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2659900317","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659900317?lang=en_us&edition=fundamental","pubTime":"2026-08-13 04:13","pubTimestamp":1786565592,"startTime":"0","endTime":"0","summary":"BioCardia Q2 FY26 net loss narrows to $1.61 million; cash rises to $4.12 million as of June 30, 2026BioCardia posted a net loss of $1.61 million in Q2 2026, narrowing from $2.05 million a year earlier","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nNDLNYSNc:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210150020.SGD","BK4139","IE00BN0W2T93.GBP","BCDA","LU0314104364.USD","NDAQ","IE00BN0W2W23.USD","IE00B64PRP62.GBP","BK4585","BK4112","LU2210149790.SGD","SG9999014039.USD","IE00BN0W2V16.EUR","BCDF","SG9999014013.SGD","IE00B3QW5Z07.USD","IE00BGHQF748.EUR","SG9999014021.USD","BK4588","LU2095319765.USD","IE00BKPKM429.USD","SG9999014005.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659072429","title":"BioCardia Q2 EPS $(0.13) Beats $(0.18) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2659072429","media":"Benzinga Earnings","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659072429?lang=en_us&edition=fundamental","pubTime":"2026-08-13 04:06","pubTimestamp":1786565208,"startTime":"0","endTime":"0","summary":"BioCardia (NASDAQ:BCDA) reported quarterly losses of $(0.13) per share which beat the analyst consensus estimate of $(0.18) by 27.78 percent. This is a 67.5 percent increase over losses of $(0.40) per share from the","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/08/61157815/biocardia-q2-eps-0-13-beats-0-18-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"BioCardia Q2 EPS $(0.13) Beats $(0.18) Estimate","news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BCDA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659690723","title":"BioCardia, Inc. Q2 Net Income USD -1.613 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2659690723","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659690723?lang=en_us&edition=fundamental","pubTime":"2026-08-13 04:06","pubTimestamp":1786565165,"startTime":"0","endTime":"0","summary":"BRIEF-BioCardia, Inc. Q2 Net Income USD -1.613 MillionAug 12 (Reuters) - BioCardia, Inc. Q2 operating income USD -1.623 million.Q2 basic EPS USD -0.13","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nPLXLGPS2D:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BCDA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659907134","title":"BioCardia, Inc. Q2 Basic EPS USD -0.13","url":"https://stock-news.laohu8.com/highlight/detail?id=2659907134","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659907134?lang=en_us&edition=fundamental","pubTime":"2026-08-13 04:05","pubTimestamp":1786565105,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nPLXLGPS2D:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BCDA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659966907","title":"BioCardia Reports Second Quarter 2026 Business Highlights and Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2659966907","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659966907?lang=en_us&edition=fundamental","pubTime":"2026-08-13 04:05","pubTimestamp":1786565105,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nTUA94NQL1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BCDA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658954024","title":"BioCardia Inc Expected to Post a Loss of 18 Cents a Share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2658954024","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658954024?lang=en_us&edition=fundamental","pubTime":"2026-08-11 05:14","pubTimestamp":1786396444,"startTime":"0","endTime":"0","summary":"BioCardia Inc <BCDA.OQ> expected to post a loss of18cents a share - Earnings PreviewBioCardia IncBCDA.OQBCDA.Ois expected to  show no change in quarterly revenue when it reports  results on August 12 for the period ending June 30 2026LSEG's mean analyst estimate for BioCardia Inc is for a loss of 18 cents per share.The current average analyst rating on the shares is \"buy\" and the breakdown of recommendations is 2 \"strong buy\" or \"buy,\" no \"hold\" and no \"sell\" or \"strong sell.\"The mean earnings estimate of analysts was unchanged in the last three months. Wall Street's median 12-month price target for BioCardia Inc is $15.50, about 1,484.4% above its last closing price of $0.98This summary was machine generated August 10 at 21:14 GMT.  All figures in US dollars unless otherwise stated.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nL8N44721R:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BCDA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657415426","title":"BioCardia Inc Expected to Post a Loss of 18 Cents a Share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2657415426","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657415426?lang=en_us&edition=fundamental","pubTime":"2026-08-07 21:50","pubTimestamp":1786110606,"startTime":"0","endTime":"0","summary":"BioCardia Inc <BCDA.OQ> expected to post a loss of18cents a share - Earnings PreviewBioCardia IncBCDA.OQBCDA.Ois expected to  show no change in quarterly revenue when it reports  results on August 12 for the period ending June 30 2026LSEG's mean analyst estimate for BioCardia Inc is for a loss of 18 cents per share.The current average analyst rating on the shares is \"buy\" and the breakdown of recommendations is 2 \"strong buy\" or \"buy,\" no \"hold\" and no \"sell\" or \"strong sell.\"The mean earnings estimate of analysts was unchanged in the last three months. Wall Street's median 12-month price target for BioCardia Inc is $15.50, about 1,532.3% above its last closing price of $0.95This summary was machine generated August 7 at 13:50 GMT.  All figures in US dollars unless otherwise stated.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260807:nL8N4441IH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BCDA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657644522","title":"BioCardia Schedules Q2 Financial Results Conference Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2657644522","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657644522?lang=en_us&edition=fundamental","pubTime":"2026-08-06 03:16","pubTimestamp":1785957393,"startTime":"0","endTime":"0","summary":"BioCardia schedules Q2 financial results conference callBioCardia schedules a Q2 2026 results release, corporate update, conference call on Aug. 12, 2026 at 4:30 p.m. EDT.Live webcast: https://event.c","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260805:nNDL3lZPfz:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B3QW5Z07.USD","BCDF","IE00B64PRP62.GBP","IE00BGHQF748.EUR","IE00BN0W2W23.USD","BK4588","SG9999014005.SGD","BK4139","BCDA","SG9999014021.USD","LU0314104364.USD","LU2095319765.USD","IE00BN0W2V16.EUR","IE00BN0W2T93.GBP","LU2210150020.SGD","BK4585","SG9999014013.SGD","IE00BKPKM429.USD","LU2210149790.SGD","SG9999014039.USD","NDAQ","BK4112"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657153527","title":"BioCardia to Host Q2 2026 Financial Results and Corporate Update Conference Call on August 12, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2657153527","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657153527?lang=en_us&edition=fundamental","pubTime":"2026-08-06 03:16","pubTimestamp":1785957360,"startTime":"0","endTime":"0","summary":"SUNNYVALE, Calif., Aug.  05, 2026  (GLOBE NEWSWIRE) -- BioCardia, Inc. [NASDAQ:BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/05/3339608/0/en/BioCardia-to-Host-Q2-2026-Financial-Results-and-Corporate-Update-Conference-Call-on-August-12-2026.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4218","HST","BK4585","BK4588","BCDA","BK4139","BK4181"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655601845","title":"BioCardia CEO Peter Altman Acquires 5,000 Common Shares Valued at $3,900","url":"https://stock-news.laohu8.com/highlight/detail?id=2655601845","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655601845?lang=en_us&edition=fundamental","pubTime":"2026-07-30 09:05","pubTimestamp":1785373544,"startTime":"0","endTime":"0","summary":"BioCardia CEO Peter Altman acquires 5,000 common shares valued at $3,900BioCardia President, CEO, director Peter Altman bought 5,000 common shares at a weighted average price of $0.78.Altman’s direct ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260730:nNDLc89V9K:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"BioCardia CEO Peter Altman Acquires 5,000 Common Shares Valued at $3,900","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BCDA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653024561","title":"Biocardia CEO Peter Altman Buys $415 of Common Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2653024561","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653024561?lang=en_us&edition=fundamental","pubTime":"2026-07-21 04:16","pubTimestamp":1784578615,"startTime":"0","endTime":"0","summary":"BioCardia CEO Peter Altman buys $415 of common stockBioCardia President and CEO Peter Altman bought 500 common shares at $0.83 each.Altman’s direct holding rose to 368,885 BioCardia common shares.Disc","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260720:nNDLbtC5L3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Biocardia CEO Peter Altman Buys $415 of Common Stock","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BCDA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.biocardia.com","stockEarnings":[{"period":"1week","weight":0.0373},{"period":"1month","weight":0.1148},{"period":"3month","weight":0.0576},{"period":"6month","weight":-0.1062},{"period":"1year","weight":-0.442},{"period":"ytd","weight":-0.192}],"compareEarnings":[{"period":"1week","weight":-0.0137},{"period":"1month","weight":0.0245},{"period":"3month","weight":0.0269},{"period":"6month","weight":0.1107},{"period":"1year","weight":0.2048},{"period":"ytd","weight":0.1229}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"BioCardia, Inc., a clinical-stage regenerative medicine company, engages in development of cellular and cell-derived therapeutics for cardiovascular and pulmonary diseases. Its lead therapeutic candidate is the CardiAMP, an autologous mononuclear cell therapy system for the treatment of heart failure and chronic myocardial ischemia; and allogeneic cell therapy for cardiac and pulmonary disease. The company is also developing allogeneic cells therapeutic platform, an investigational culture expanded bone marrow derived mesenchymal cell therapy, which is in Phase I/II trial for the treatment of ischemic heart failure. In addition, it offers the Helix biotherapeutic delivery system that delivers therapeutics into the heart muscle with a penetrating helical needle from within the heart; and Morph deflectable guides and sheaths. The company is based in Sunnyvale, California.","yearOnYearQuotes":[{"month":1,"riseRate":0.625,"avgChangeRate":0.066663},{"month":2,"riseRate":0.5,"avgChangeRate":-0.017269},{"month":3,"riseRate":0.25,"avgChangeRate":-0.022375},{"month":4,"riseRate":0.375,"avgChangeRate":0.007226},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.09523},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.005776},{"month":7,"riseRate":0.444444,"avgChangeRate":-0.051846},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.066302},{"month":9,"riseRate":0.375,"avgChangeRate":0.008782},{"month":10,"riseRate":0.375,"avgChangeRate":-0.049332},{"month":11,"riseRate":0.5,"avgChangeRate":0.042585},{"month":12,"riseRate":0.375,"avgChangeRate":-0.012187}],"exchange":"NASDAQ","name":"BioCardia","nameEN":"BioCardia"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.47.1","shortVersion":"4.47.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"BioCardia(BCDA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest BioCardia(BCDA) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"BioCardia,BCDA,BioCardia股票,BioCardia股票老虎,BioCardia股票老虎国际,BioCardia行情,BioCardia股票行情,BioCardia股价,BioCardia股市,BioCardia股票价格,BioCardia股票交易,BioCardia股票购买,BioCardia股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"BioCardia(BCDA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest BioCardia(BCDA) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}